Gp130 receptor signaling mediates α cell dysfunction in a rodent model of type 2 diabetes
Samuel Z.Chow, MadeleineSpeck, PriyaYoganathan, DominikaNackiewicz, Ann MariaHansen, MetteLadefoged, BjornRabe, StefanRose-John, Peter J.Voshol, Francis C.Lynn, Pedro L.Herrera, WernerMüller, HelgaEllingsgaard, Jan A.Ehses
DOI: 10.2337/db13-1121 Published 2 May 2014
Samuel Z. Chow
1Department of Surgery, Faculty of Medicine, University of British Columbia, Child & Family Research Institute, Vancouver, BC, Canada.
4Institute of Metabolic Science, University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, United Kingdom.